SpinalCyte, LLC Presents At MENA Private Equity & Venture Capital Summit

HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using human dermal fibroblasts, announced the October 25-26 Presentation given by President and CEO, Pete O’Heeron at MENA (Middle East North Africa) Private Equity & Venture Capital Summit in Riyadh, Saudi Arabia.

About SpinalCyte, LLC

Based in Houston, Texas, SpinalCyte, LLC is a tissue engineering technology company founded for the purpose of developing an innovative and autologous solution for spinal nucleus replacement using human dermal fibroblasts. The goal of SpinalCyte is to develop a cartilage regeneration technology using autologous dermal cells harvested from the patient. To date, SpinalCyte has been funded entirely by angel investors.